QIAGEN OncoLand is an oncology database with integrated visualization software that helps cancer researchers easily explore high-quality public and private cancer genomics data and cancer datasets. Leverage QIAGEN’s world-class analysis pipelines, cancer dataset curation and data management tools to accelerate your oncology research projects – from cancer biomarker discovery, new target identification and target validation, to drug repositioning and indication discovery.
Used in nearly all stages of drug development (from discovery to preclinical and clinical research), OncoLand oncology database encompasses multi-omics platforms, while providing a standardized pipeline for incorporation of data, with controlled vocabularies for associated information on cancer datasets. Every project is expertly curated using an extensive set of controlled vocabularies to make the data FAIR (findable, accessible, interoperable and reusable).
No need to reinvent the wheel: QIAGEN’s bioinformatics team spends thousands of computing, curation and download hours each year to keep up with rapidly growing cancer genomics data so you don’t have to. By using our pre-curated cancer datasets and powerful analytics, you can:
-Dr. Arthur Liberzon, Bioinformatician, Alkermes, Inc.
Using QIAGEN OmicSoft OncoLand oncology database, the possibilities for biological discoveries from cancer datasets are endless:
Explore our powerful solutions for biomarker and target discovery
Explore how QIAGEN OmicSoft OncoLand can help you dig deeper into your ‘omics data to extract novel insights